Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
aMoon Fund
company
About
aMoon is a leading healthtech & life sciences venture capital firm.
- 11 - 50
Highlights
Details
- Industries
- Biotechnology,Health Care,Venture Capital
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- Venture Capital
aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science to accelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Investments
Number of Investments
Number of Lead Investments
9
2
aMoon Fund has made 9 investments. Their most recent investment was on
Nov 9, 2022, when Ibex Medical Analytics raised $10M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 9, 2022
Ibex Medical Analytics
|
Debt Financing | $10M | Analytics | — |
|
May 31, 2022
Ultima Genomics
|
Series Unknown | $600M | Biotechnology | — |
|
May 31, 2021
DayTwo
|
Series B | £26.30M | Health Care | — |
|
Mar 23, 2021
Absci
|
Series Unknown | $125M | Artificial Intelligence | — |
|
Mar 9, 2021
Ibex Medical Analytics
|
Series B | $38M | Analytics | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
